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Abstract: The number of novel bacteriophage sequences has expanded significantly as a result
of many metagenomic studies of phage populations in diverse environments. Most of these
novel sequences bear little or no homology to existing databases (referred to as the “viral dark
matter”). Also, these sequences are primarily derived from DNA-encoded bacteriophages (phages)
with few RNA phages included. Despite the rapid advancements in high-throughput sequencing,
few studies enrich for RNA viruses, i.e., target viral rather than cellular fraction and/or RNA rather
than DNA via a reverse transcriptase step, in an attempt to capture the RNA viruses present in
a microbial communities. It is timely to compile existing and relevant information about RNA
phages to provide an insight into many of their important biological features, which should aid
in sequence-based discovery and in their subsequent annotation. Without comprehensive studies,
the biological significance of RNA phages has been largely ignored. Future bacteriophage studies
should be adapted to ensure they are properly represented in phageomic studies.
Keywords: bacteriophage; RNA viruses; RNA; Cystoviridae; Leviviridae
1. Introduction
Bacteriophages, commonly known as “phages”, are the most abundant biological entities on
the planet, with approximately 1031 in the biosphere [1]. Phages were independently identified in
1915 by Twort and in 1917 by d’Hérelle [2,3]. They are viruses which can alter microbial populations,
with a major role in diversity patterns of microbial populations [4]. They were first recorded as
antibacterial agents by d’Hérelle and quickly developed into clinical aids against bacterial infections,
particularly across Eastern Europe [3,5,6]. The first known RNA phage, f2, which infects Escherichia coli,
was described more than 40 years after the discovery of DNA phages [7]. Weissmann (1974), suggested
that RNA phages offered a means to examine basic biological processes at an in-depth molecular
level [8]. Since their identification, RNA phages have served as valuable models for understanding
not just essential viral processes but also fundamental molecular mechanisms such as RNA genome
replication, translational control, and gene regulation [9–12].
The RNA phage MS2, isolated by Alvin John Clark in 1961 and highly similar phage f2 [13],
have become key models in molecular biology and genetics. The MS2 phage coat protein gene was the
first gene to be completely sequenced in 1972 by Friers and his colleagues [14]. In addition, the genome
of the MS2 phage was the first to be fully sequenced in 1976, also by Walter Friers and colleagues [15].
This preceded the sequencing of the first DNA based genome of phage phiX174 in 1977 [16]. RNA
phages have also provided scientists with a model system for understanding the biology of many
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human pathogenic viruses such as Hepatitis, Influenza, and HIV [17–19]. For example, the stem loop
structure of MS2 bacteriophage RNA has become a common tool for studying the key group antigen
(Gag) polyprotein of HIV by replicating the protein–protein interactions [20].
While there is a substantial amount of literature and studies involving the bacterial component of
the gut microbial system, there is still relatively little known about the human virome, and in particular
the bacteriophage fraction of the microbiome. In addition, most newly identified phage sequences do
not have known counterparts in viral databases, and these unknown sequences are sometimes referred
to as the “viral dark matter” [1]. Phages influence microbial populations by infecting and destroying
specific species of bacteria. Alternatively, temperate or lysogenic phage are capable of integrating their
genomes into the host bacterium’s chromosome, often providing bacteria with a fitness advantage
while the phage remains dormant and replicates in tandem with the host chromosome [21].
The genomic composition of phages are extremely diverse and are composed of either DNA or
RNA, which can in turn be either single-stranded (ss) or double stranded (ds). Single-stranded RNA
genomes can exist in two variants; negative sense (−ve) and positive sense (+ve). This depends on their
orientation and whether there is a prerequisite for transcription prior to translation. Some eukaryotic
RNA viruses use reverse transcriptase to replicate their genetic material through a DNA intermediate,
while no DNA stage has been observed amongst bacterial RNA phages to date. In addition,
the genomes of phages are described as being “mosaic”, composed of individual modules that may
appear in other phages but in an alternative arrangement [22,23]. While phages can evolve through
the accumulation of mutations, within environments they are responsible for vast amounts of genetic
recombination and horizontal gene transfer events [24]. Altogether, these attributes make both DNA
and RNA phage genomes very diverse and difficult to classify.
Typically, phage infection proceeds via adsorption, penetration, replication, assembly, and release.
Briefly, phages use specialized surface receptor-binding proteins to interact with and adhere to their
specific cognate host receptor. Phages then use various mechanisms to breach the cell wall of bacteria
and inject their genomes into the cytoplasm of the host. Infection can then proceed via a lysogenic
(temperate) or lytic (virulent) lifecycle. Virulent phages hijack the host’s cellular components to direct
the replication of the phage’s genome and produce the necessary viral encoded proteins. Once the
phage genome is replicated, it is packed into self-assembled viral particles. Phages induce host cell
lysis and the assembled phage progeny are released into the surrounding environment for successive
infections. Temperate phages that can replicate through lytic or lysogenic lifecycles are typically able
to integrate into the bacterial chromosome and are subsequently replicated in tandem with the host
genome. Temperate phages can also be maintained through formation of an episome within the host,
which is disseminated through a population via cell division [25]. Temperate phages can respond to
host cues from environmental stresses to initiate the lytic cycle and release phage progeny. They have
been shown to dramatically affect susceptible bacterial populations through transfer of novel genes
to their host, they can provide resistance to subsequent phage predation and can also alter host gene
expression [26].
Although studies into the phage component of the microbiome have increased rapidly in recent
years, databases are dominated by phages with DNA genomes. According to the latest (2017) report by
the International Committee for the Taxonomy of Viruses (ICTV), viruses are separated into 134 families.
The same report separated RNA phages into only two families; Cystoviridae (dsRNA phage) with
1 genus, Cystovirus, with 7 recognised species, and Leviviridae (ssRNA phage), with 2 genera, Levivirus
and Allolevivirus, each of which contain two species [27,28].
A recent examination of RNA phage populations in 2016 by Krishnamurthy and Wang, through
metagenomic dataset analysis, led to the identification of 122 partial genomes of novel RNA phages [29].
The host range of DNA phages typically varies greatly in contrast to that of RNA phages, which were
all thought to target members of the Proteobacteria phylum. However in that study, an RNA phage was
identified from a transcriptome of pure culture of Streptomyces avermitilis, a Gram-positive bacterium,
known as Streptomyces phage phi0. This phage is thought to belong to the Cystoviridae family based
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on RNA-dependent RNA-polymerase (RdRp) analysis. This was the first report of an RNA phage
with a natural affinity for a Gram-positive host. In addition, a recent pre-print has described an RNA
virus, a planarian-infecting Nidovirales, with a genome of 41.1 kb in length, significantly longer than
the previous largest RNA virus genome of 30 kb [30]. These findings highlight that there are certainly
many RNA viruses yet to be discovered and described, including RNA phages.
This review focuses on examining known RNA phages, both dsRNA and ssRNA, which target
bacterial cells. Outlined are their mechanisms of adsorption through to the release of progeny. Future
endeavors may use conserved features of RNA phages as genetic signatures to aid in prospective
metagenomic exploration of RNA phages in the “dark matter” via sequence-based targeting.
2. Cystoviridae
Currently there are seven recognized species of Cystoviridae listed in the 2017 ICTV report.
The type species of Cystovirus family is phi6, which for a long time was thought to be unique as a
dsRNA phage. The Cystoviridae have a tri-segmented, linear dsRNA genome, with the concatenated
genome varying size from 12.7 kb (phi2954) to 15.0 kb (phi8). Individual genome segments range
in size from 2.9 kb to 6.4 kb (Figure 1). The three genome segments, large (L), medium (M) and
small (S) are transcribed into separate polycistronic mRNAs that are predicted to be translated by
the host machinery into 12 proteins. A lipid membrane envelops a double-layered proteinaceous
nucleocapsid (NC) [31].
Figure 1. Virion of Pseudomonas phage phi6, the type virus of the Cystoviridae family. The virion and
genes encoded by the tri-segmented genome of this phage are color co-ordinated. The grey circle
represents the membrane encapsulating the virion. See text regarding gene information. (This figure
was reproduced based on other images [28,32,33]).
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Cystoviridae genes are ordered into functional units within the segments: L-segment contains
genes for the virion core (P1, P2, P4, and P7), the M-segment encodes the complex essential for host
recognition (P3 and P6) and the S-segment is responsible for the shell protein of the nucleocapsid (P8
(except in phi8), P9, P12, and P5) [34–42]. P5 and P11 are transcript variants of the same gene [43].
The noncoding regions that flank the coding sequences within the segments are required for efficient
genome replication and packaging. The 5′ untranslated region (UTR) of the plus strand region encodes
a cis-acting RNA sequence known as the pac sequence [44]. The segment-specific pac sequence is
composed of 200 nucleotides located within a number of stem-loop structures. The pac sequences act
in unison with other fundamental structural elements to ensure the correct packaging of the genome
when required.
The integral-membrane, fusogenic P6 protein is responsible for securing the receptor-binding
protein of Cystoviridae, P3, to the viral envelope. It is this multimeric spike protein, P3, which enables
the recognition of the host bacteria receptor pilin, the protein monomer making up bacterial pili,
by the phi6 phage. The P3 protein of phages phi8, phi12, phi13, and phiYY have been suggested to
be a single polypeptide or a multimer [45]. The P3 protein of phi6 adsorbs to host type IV pili of
its target, Pseudomonas syringae, which then retracts to bring the phage into close proximity of the
host membrane [46,47]. This form of attachment is also exploited by phiNN and phi2954 [37,40].
Other members of Cystoviridae, such as phi8, phi12, phi13, and phiYY, utilize their heteromeric P3
protein to attach to the lipopolysaccharide (LPS) on the cell surface [48]. The P3 protein of these species
differs in its composition as it contains two or three different polypeptides (P3a, P3b and, in some
cases, P3c). The P6 protein is activated following the removal of P3 and then mediates the fusion of the
viral membrane with the host membrane to release the NC into the periplasmic space.
The loss of viral membrane around the NC enables the muralytic (peptidoglycan-degrading)
enzyme P5, located on the NC surface, to degrade the peptidoglycan layer of the bacterial cell
wall [49,50]. The permeabilization of the host plasma membrane facilitates the translocation of
the NC across the cytoplasmic membrane of the host cell through an endocytosis-like process,
driven by P8 [51,52]. Upon entry into the cytoplasm, the P8 shell of the NC dissociates to reveal
the naked dodecahedral polymerase complex (PC). The release of P8 stimulates the PC, which is
transcriptionally active. This is the characteristic mechanism dsRNA viruses exploit in order to
replicate their genome—delivery of the nucleic acids in a specialized icosahedral capsule containing the
necessary RNA metabolism enzymes such as mRNA synthesizing enzymes. This nano-compartment
enables the dsRNA genome to remain “hidden” from any antiviral mechanisms of the host and avoids
dsRNA induced host responses [53]. It also provides a safe environment for phage replication and
translation. The dimeric P7 protein acts as an assembly and packaging cofactor by accelerating the rate
of immature PC assembly through stabilization of the entire complex [54,55].
The core particle is composed of P1, P2, P4, and P7. These proteins are involved in the transcription
of the phi6 genome. The monomeric RdRp of the P2 gene is activated by PC entry into the cytoplasm.
This enzyme catalyzes the semi-conservative transcription of polycistronic mRNAs within the core
particle [56]. Bacterial hosts lack the capability to synthesize complementary strands from the RNA
template, so all characterized RNA viruses, including phages, encode their own enzymes. The RdRp
attaches to the 3′ end of the single-stranded mRNA transcripts and through primer-independent
de novo initiation it efficiently replicates and transcribes the phage genome [57,58]. The suggested
transcription mechanism involves the dsRNA genome unwinding as it is pulled through one channel
of P2 and nucleotide triphosphates (NTPs), oligonucleotides, manganese (Mn2+) and magnesium
(Mg2+) ions entering through another [59]. Initially the template strand overextends and it locks into
a “specificity pocket” [59]. The strand then reverses, in the presence of two cognate NTPs, to form
the functional initiation complex. The reaction is primed through the activity of one of the NTPs as it
serves as the carboxyl-terminal domain of the protein. It has been suggested that Cystoviridae control
transcription through an interchange of two independent mechanisms (a) plus-sense initiation sites
are preferred by the polymerase and (b) initiation competent ssRNA templates have more available
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transcription initiation sites [60]. Initiation is the rate-limiting step of transcription, located at the
3′-terminal cytidine nucleotide of the −ve ssRNA template.
By directly releasing the mRNA transcripts into the cytoplasm, the dsRNA genome is never
exposed to the host cytoplasm which helps the phage to avoid host defense mechanism activation.
The mRNA transcripts are used as templates for translation of the necessary proteins. The early stage
of infection is characterized by equal amounts of mRNA from L, M, and S segments [61,62]. However,
only the L-segment transcripts are efficiently produced in this early stage, to give rise to an increased
level of PC proteins and the formation of empty PCs.
The large free-strand +ve ssRNA is then translated to form P1, P2, P4, and P7, which are
subsequently assembled to form empty PCs [43]. The hexameric nucleoside triphosphatase (NTPase)
motor of P4 directs the bundling of the three genome segments in the form of +ve ssRNA into the empty
PCs by recognition of 5′ pac sequences [44,63]. This packaging is controlled through the expression
of segment-specific binding sites on the PC. Binding sites specific for the S-segment are exposed
initially to allow P4 to package the S-segment into the empty PC. A conformational change of the
PC alters the binding site to become M-segment specific to package this segment of the genome into
the viral progeny. Another change allows the packaging of the L-segment. Once the PC expands to
a threshold size, these +ve ssRNA transcripts are then converted into dsRNA by a single round of
negative strand synthesis of RdRp P2 [64]. Studies by Pirttimaa and colleagues (2002) found that of the
12 P4 hexamers, one is both functionally and structurally unique [65]. Although studies focused on the
basic molecular mechanisms of phages have exploded in recent years, the exact transcriptional and
translational processes of Cystoviridae are yet to be fully described in exact detail.
The size and organization of this PC is regulated through the activity of inner capsid protein P1
and P4 [55,66,67]. P1 is conserved throughout dsRNA viruses, although it appears to vary in multimeric
status [55,68]. Transcription is initiated following effective replication of the dsRNA genome. As the
infection progresses, the M and S segment mRNA predominate to produce the proteins essential to
virion assembly. The naked PC is encapsulated in a newly synthesized NC shell. The membrane
protein P9, along with morphogenic P12, have crucial roles in construction of a new phospholipid
membrane around the NC particle from the host plasma membrane [69]. The spike protein complex
of P3 and P6 is the last component attached to the surface, to ensure the progeny are capable of
receptor recognition.
Cystoviridae are categorized as virulent phages as they induce lysis of their host bacterium at
the end of the infection cycle in order to release viral progeny, through P5 and P10 activity [49,50].
However, recent findings have shown that phi6 is capable of forming a pseudolysogenic carrier state
within its host [70]. Cystoviridae species phage phi6 targets the Gram-negative bacterium, Pseudomonas
syringae, an important plant pathogen. This phage was first isolated in the 1970’s in the USA from
Pseudomonas-infected bean straw [71].
There have recently been six additional Cystoviridae isolated and characterized in the 2017 ICTV
report with another five requiring further analysis. Their genetic and structural similarities with phage
phi6 suggest that there will be an expansion of this phage taxonomic family with further classification
required. Sampling of various legumes in the USA have resulted in the isolation of additional
dsRNA phages but these have not been characterized beyond their sequences [48,72,73]. Assorted
environmental sources in Europe and Asia have yielded more novel dsRNA phages: Pseudomonas
phage phiNN was isolated from a freshwater sample in Finland, while Pseudomonas phage phiYY came
from hospital sewage waste in China [37,42]. Phage isolate phiYY has been found to target P. aeruginosa
strains, an opportunistic pathogen of immuno-compromised individuals. This suggests there may be
potential to develop a phage therapy to combat Pseudomonas infections in these individuals.
It is clear from the recent isolations of Cystoviridae from multiple environments, with only a single
member infecting a Gram-positive host, that there are many more RNA phages yet to be discovered.
Recently, Alphonse and Ghose (2017) examined known Cystoviridae using their encoded RdRp [32].
While ssRNA phage genomes have high mutation rates [74], RdRp appears to be conserved amongst
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RNA phage genomes and thus might be a good candidate as a genetic signature to identify further
RNA phage sequences. However, identification of Cystoviridae in metagenomic datasets using a marker
such as the RdRp is complicated by the tri-segmented nature of the Cystoviridae genomes. Therefore,
sequence based detection of all three genomic segments of Cystoviridae, particularly if they are divergent
from sequences present in public repositories, will be challenging. Incorporation of genetic tags from
each of the three segments will greatly enhance de novo efforts of finding Cystoviridae members.
3. Leviviridae
The Leviviridae family encompass phages with a positive-sense single stranded, monopartite RNA
genome of 3.3–4.3 kb in length. The nonenveloped, somewhat spherical virion capsid is composed
of 178 copies of the dimeric coat protein (CP) and a single copy of the maturation protein (Figure 2).
The 5′ end of the genome carries a triphosphate cap.
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There are two genera of Leviviridae; the Levivirus and Allolevivirus. These genera were historically
differentiated throu h serological cross-reactivity, sedimentation, molecular weight and density [76].
More recently, t e number of known genes in their genomes have been sed to distinguish between
Levivirus a d Allolevivirus members, with three and four, respectively (Figure 2). These genera are
subdivided into genogroups; Levivirus has MS2-like (genogroup I) and BZ13-like (genogroup II) and
Allolevivirus has Qß-like (genogroup III) and F1-like (genogroup IV) [27].
Leviviridae phages that target E. coli, “coliphage”, which are male-specific, adsorb along the
fertility (F) pilus, coded by the F-plasmid of Escherichia coli, or the chro osomal marker Hfr, whereas in
non-coliphage species alternative pili are exploited [77]. Alternatively, coliphages that can infect cells
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via the cell wall are classified as somatic [78]. The presence of enteroviruses in water from pollution is
often detected through the identification of RNA coliphages as biomarkers [79]. Phages that utilize
F-pili are classified as male-specific phages. The way in which the Leviviridae phages induce lysis of their
host is a notable difference between the genera; Levivirus phages encode a separate lysis polypeptide,
whereas Allolevivirus phages utilise their maturation protein in lysis mediation [80,81]. These proteins
are two canonical “single gene lysis” (SGL) systems that are utilised by small phages, the third is the
E lysin from phage φX174, a ssDNA Microviridae representative [82]. The lysis mechanism, and specific
protein where applicable, is fundamental to the lifecycle of the phage.
3.1. Levivirus
The type species of Levivirus is the Enterobacteria phage MS2, a member of the MS2-like phages
(genogroup I). Phages of the Levivirus genus infect their host targets through the initial adsorption
of the virion along the sides of pili using the “maturation A-protein” (MatL) as the receptor binding
protein [83]. This results in the self-proteolytic cleavage of the A-protein into at least two fragments
and a structural change of the F-pilus [84]. This induces the release of the phage RNA into the host
bacterium. Studies have reported that the two largest polypeptide components are transferred into the
host along with the genomic RNA [84]. The fragmented MatL binds the RNA at two distinct regions:
the MatL coding region and the 3′-UTR [85]. It appears that MatL-RNA complex may be injected into
the cell as opposed to free RNA, suggesting that the MatL protein may have a greater biological role
than originally envisaged [84]. The exact mechanism of how the MatL-RNA complex gains entry to
the host remains undescribed, but could involve a type IV secretion system (T4SS) homolog [86]. It has
been postulated that MatL may also contribute to the replication process of the RNA genome.
As the nucleic acid is a single copy of +ve ssRNA, it functions both as the genome template
and mRNA upon infection. Thus, there is constant competition between replication and translation
processes as the ribosome and replicase run in opposite directions along the template strand [87].
The two events are independent of each other with the secondary structures of the +ve ssRNA strand
and formation of a complementary negative strand of RNA maintaining this equilibrium. It has
been noted that in the 3′-terminal sequence of the Levivirus genomes, there is a signature sequence of
5′-ACCACCCA-3′ [88].
For effective genome replication, Leviviruses encode a copy of RdRp that codes for the catalytic
ß-subunit of the replicase. This protein associates with three host proteins: ribosomal protein S1 [89]
and the translational elongation factors EF-Tu and EF-Ts [90], to form a functional polymerase unit,
the holoenzyme. The role of EF-Tu has been established as delivering an aminoacyl-tRNA to the
ribosome when in its GTP-bound form [91]. This GTP is hydrolyzed to form GDP-bound EF-Tu
following a codon anti-codon match within the ribosomal complex. This displaces the EF-Tu and EF-Ts
binds to the GDP-bound EF-Tu and removes the GDP molecule. This allows the EF-Tu to be recycled
for further elongation rounds [92,93]. Sequestration of these elongation factors inhibits initiation of
translation. The S1 protein functions as a translational initiation factor. The sole purpose of this protein
is to recognize the template plus strand, the core-complex of the three remaining proteins is sufficient
to synthesize new +ve ssRNA strands [94].
Studies have shown that there are two internal sequences which are key to the recognition of
the plus strand by the replicase, the S site and M site. [95]. The S site is described as being a uracil
rich sequence of approximately 100 nucleotides, located just before the initiation codon of the coat
protein. The secondary structure of the S site is poorly defined. The M site is of similar length, forms
a branched stem-loop structure and resides within the replicase coding region [96]. These two sites
are simultaneously bound by the S1 protein to allow for effective replication by the replicase through
enhanced recognition of the template to the active site [97].
The RNA template is protected from cellular nuclease degradation through an unknown
mechanism. There is an additional host factor required for successful translation that has been
isolated but not genetically identified in the case of Levivirus species. This protein does not interact
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with the polymerase machinery but instead binds directly to the 3′ terminal of the mRNA template [98].
The replicase will associate to the start site and initiate negative-strand synthesis by replicating through
the genome. This strand is used to synthesize new +ve ssRNA genomes for the viral progeny.
As the infection cycle reaches the end-stage, the CP-dimers bind the replicase gene start site,
located within a hairpin-structured operator, and act as translational repressors [99,100]. This results in
a packaging signal that stimulates the assembly of functional viral progeny. At the same time, there is
an increase in quantities of the lysis protein, with a single lysis protein required for each phage progeny.
Since the lysis protein lyses the cell without affecting the integrity of the peptidoglycan network, and in
the absence of muralytic enzyme activity, it is referred to as an “amurin” [101]. Research focused on
this protein has revealed that it is primarily localized in Bayer’s patches, the periplasmic zones of
adhesion between the inner and outer membrane [102]. The exact mechanism by which this 75-amino
acid lysin induces host lysis is not exactly known [103]. However, the current proposal is that the
lysis protein forms lesions and hydrophobic pores in the inner membrane that dissipates the proton
motive force (PMF) [104]. This alteration in PMF activates autolysis of the bacterial host through
certain enzymes such as DD-endopeptidases and lytic transglycosylases. Supporting research has
shown alteration in the average length in glycan strands and degree of cross-linkage, suggesting the
activation of the aforementioned enzymes [105].
Nonetheless, the molecular information and functioning schema of such an autolytic pathway
have yet to be identified [82]. Recent findings have indicated that the lysis of host cells by MS2 lysin
is dependent on a range of host factors, including host chaperone DnaJ [106]. This post-translational
regulator allows for another level of control of both quantity and activity of the lysis protein of MS2.
Translation of the phage genes requires the ribosome to associate with the RNA through a
Shine–Dalgarno sequence, the start codon and the host ribosomal S1 protein. The S1 protein can bind
the S site, as mentioned above. This creates a situation whereby the S1 protein of the ribosome and
replicase are competing for the same RNA binding site.
There are a variety of systems that regulate protein synthesis, including: RNA secondary structure,
ribosome access to the initiation codon, and folding kinetics [107–109]. The secondary structures of the
+ve ssRNA are the predominant factors in determining different protein yields; e.g., the CP gene is free
from any secondary structures as it is required in high copy numbers (178 per virion), whereas the
replicase gene is trapped in tight secondary structures as only one copy per progeny is required [110].
The open reading frame (ORF) of the coat protein is readily available for the ribosomal translation.
As the ribosome moves along the RNA transcript, it disrupts the secondary structure to allow hidden
genes to be translated. Following CP gene translation, the initiation codon of the replicase gene
becomes available, resulting in the synthesis of the replicase ß-catalytic subunit. The translation of the
lysis and replicase gene is dependent on successful translation of the CP gene.
Newly synthesized viral particles require only one copy of the lysis protein and the MatL
protein [111–113]. The ORF of the lysis gene overlaps the replicase gene in a +1 frameshift, with the
termination sequence of the lysis protein located in the coding region of the replicase gene [103,114].
Studies by van Duin and his colleagues (1990) on the translational control of the lysis protein provided
key information as to the role of secondary structures in transcriptional regulation. Their work
demonstrated that the formation of a stable hairpin in the RNA between the Shine–Dalgarno sequence
and the start codon of the lysis gene, represses the expression of the lysis gene. Following successful
transcription, during translation there is incomplete dissociation of the ribosome from the mRNA as it
creates the CP protein [115,116]. The ribosome backtracks to reinitiate at the start codon for the lysis
protein in approximately 5% of translational cycles [117,118]. The lysis protein is produced at low
levels towards the ends of the infection cycle. This allows for gradual accumulation of the lysis protein
to ensure that the viral progeny have sufficient time to mature.
The MatL protein is only transcribed from newly synthesized genome templates [119]. The strong
secondary structure formed by the Shine–Dalgarno sequence and the S1-binding sequence prevent
translation of the 5′-end in normal mRNA structure, where the MatL gene is positioned. In nascent RNA
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strands, there is an alternate, shorter hairpin structure created that enables translation of the maturation
gene in the 5′ terminal by allowing access and binding of the ribosome. This RNA-folding intermediate
of newly-synthesized strands enable the ribosome access to the start codon of the A-protein.
A recently isolated RNA phage for Acinetobacter species, AP205, was found to have an unusual
genome structure with the lysis gene located in the 5′ terminal [120]. Although the genome of
AP205 mirrors the typical Levivirus genome map, the secondary structure and 3′-UTR follows that of
Allolevivirus. This phage has yet to be approved as a Levivirus. Potential Leviviruses of Pseudomonas,
phages PPR7 and PRR1, have also been isolated and characterized, both exhibit particular hallmarks
of Levivirus phages [121–124].
3.2. Allolevirus
The type species of Allolevivirus is Qß, the representative of the Qß-like phages (genogroup III).
Species of Allolevivirus contain a longer version of the genome with an extension of the C-terminal of
the CP gene [76]. The presence of this minor-CP A1 (MCPA1) protein, also known as the ‘read-through
protein’, is a feature unique to Allolevivirus phages [125]. Both the MCPA1 and the maturation A2
(MA2) proteins are essential for host attachment [76]. The majority of Allolevivirus members were
found to encode an Arg-Gly-Asp (RGD) motif, essential for host cell recognition and attachment,
within their MCPA1 and/or MA2 [88]. This motif is absent in the Levivirus phages. Similar to the
signature 3′-terminal sequence of Levivirus, Allolevivirus species contain a 5′-TCCTCCCA-3′ within the
3′-terminal of their genome [88].
The underlying translation and replication mechanisms are similar to Levivirus with minor
variations. The host factor that associates with the functional replicase has been isolated, purified
and genetically characterized for Qß as the protein encoded by the host factor of Qß (hfq) gene of
E. coli [126,127]. This nonspecific ssRNA binding protein, Hfq, aids polymerase association to the 3′
end of the +ve ssRNA template. The start of the 5′-terminal begins with a GG sequence. There is a
nontranslated A residue attached to the extreme 3′ terminus in a CCA sequence, following activity
of the terminal nucleotidyl transferase (TNTase) domain of RdRp [128–130]. This does not serve as a
template nucleotide, instead RNA synthesis begins at the penultimate C residue.
The transition between replication and translation is similar to the above mentioned Levivirus,
with a slight change; the translation of the (MA2) is controlled in a temporal manner as opposed to
a structural intermediate. This is dictated by the length of time it takes for the polymerase to move
from the start site of the maturation gene to the complement of the Shine–Dalgarno sequence [131,132].
Once it has been translated, these two sequences bind to form a strong secondary structure to
prevent continuous translation of the same gene. The additional MCPA1 protein is formed following
ribosomal read-through of the leaky-stop codon (UGA) of the CP gene [118]. It is read as a tryptophan
codon (UGG), which promotes gene expression of the MCPA1 protein. The ribosome occasionally,
in approximately 5% of cases, translates past this leaky termination sequence for an additional
600 nucleotides to form a C-terminal extension of the CP [133]. This protein is incorporated in
low quantities into viral progeny and is essential for successful infection. Studies of the amino acid
sequence and the three-dimensional structure of the MCPA1 protein, have shown it to be unique to
the small group of Allolevivirus phages [133]. The MA2 and the MCPA1 protein, whose exact role is
unknown as of yet, are essential for successful infection of pili-positive hosts
Another notable difference in the infection pattern of Allolevivirus is the absence of a lysis gene in
the genome. Instead, the MA2 protein has a secondary function to induce the lysis of the host
cell for release of viral progeny [134]. The MA2 protein is referred to as an amurin as it does
not destroy the peptidoglycan layer directly through muralytic activity. It is also known as an
“antibiotic protein” due to the similarity in function to antibacterial agents which target cell walls [135].
It has been reported that MA2 induces host cell lysis by inhibiting the enzymatic activity of MurA,
a UDP-N-acetylglucosamine-enolpyruvyl transferase. This is an essential enzyme in the production
of peptidoglycan as it catalyses the first committed step, the biosynthesis of murein precursor [136].
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At the next stage of cell division, the inhibition of cell wall biosynthesis leads to host lysis and release
of the phage progeny.
A study by Friedman et al. (2009), noted that the sequences of both Levivirus and Allolevivirus
genera had strong homogeny across position of ORF, length of proteins and the catalytic ß-domains of
the RdRp [88]. The conservation of the YGDD motif of the replicase protein across all positive-sense
ssRNA viruses was recorded throughout the Leviviridae.
Although both Levivirus and Allolevivirus phages target the pilus of their hosts as receptors to
initiate, the fact there is no conserved infection mechanism suggests that there may be varying
mechanisms for the RNA to enter the cell. Originally thought to only affect plasmid-encoded
appendages, there have been Leviviridae specific for genome-encoded pili of Gram-negative bacteria,
such as Pseudomonas phage PP7 and Acinetobacter phage AP205.
4. Discussion
Although there have only been a limited number of RNA phages identified to date, their “true”
diversity and abundance in nature remains unknown. Current approaches used for the isolation,
selection, and purification of viral particles, including precipitation by polyethylene glycol (PEG) and
caesium-chloride (CsCl) gradient purification, are almost certainly biased against RNA phages [137].
The selection of DNA phages in these methods goes a long way to explaining why RNA phages are
under-represented in genome databases.
The fragile nature of RNA and the widespread presence of RNases in human and animal derived
samples also hinders studies involving RNA phages. The development of RNA phage-selective
isolation protocols will also greatly enhance our endeavors. For example, separation of DNA and RNA
fractions of samples and complete eradication of unwanted RNase is recommended. It should also
be noted that the low abundance of RNA phages in databases will result in reduced “hits” for novel
sequences. As research into the RNA section of the phage community is expanded, we can expect the
databases to become more representative of the wider RNA phage community.
An interesting paper recently proposed that members of the Picobirnaviridae family may not be
eukaryotic viruses as originally thought, but may in fact represent a novel family of RNA phages [138].
This research involved analysis of bacterial ribosome binding sites (RBS) upstream of the coding
sequences in their bi-segmented, dsRNA genomes. It was noted that an RBS motif, thought to be
unique to prokaryotic-infecting viruses, was enriched in the picobirnaviruses. This finding suggests
that these dsRNA viruses could be classified as putative bacteriophages. Furthermore, an additional
study has supported this hypothesis by proposing that picobirnaviruses are in fact a novel RNA phage
family of high genomic diversity [139]. This type of analysis demonstrates the possibility that more
members of RNA virus populations may in fact be mischaracterized. A more robust method for
classification of RNA phages would help to resolve this issue.
Identifiable RNA phage-specific domains, such as the RdRp gene, capsid gene, maturation protein
gene, or the NTPase gene, can serve as features which one could use to mine metagenomic databases
for RNA phages. However, since the RdRp gene is conserved amongst RNA viruses, unique genetic
elements of Leviviridae and Cystoviridae families should also be used in specific studies. Contigs with
homologs to both the leviviral and cystoviral RdRp gene are potential RNA phages and should be
subjected to further analysis. Based on the recent studies mentioned above, homologs to the RdRp
gene of picobirnaviruses should also be included [138]. The study by Krishnamurthy and colleagues
which identified 20 unique RNA phage phylotypes utilized nucleotide identity to the RdRp and the
maturation gene to categorize these phages [29]. The specific 3′-terminal sequences of Levivirus and
Allolevivirus members could be used to further classify these phages. Signature features of Cystoviridae
members, such as the muralytic enzyme gene or the nucleocapsid shell protein gene, could also serve
as genetic signatures when screening the databases for RNA phages [42].
A common theme of this review is the need for greater efforts to be directed towards the discovery
of more RNA phages for all potential applications, such as tools for advancing molecular biology
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and as potential phage therapeutics. The rise in antimicrobial resistance across bacteria is not a
novel problem but it is alarming. The host range of RNA phages could offer therapeutic potential
against some of the World Health Organizations’ (WHO) list of deadly pathogens, including some of
the Gram-negative members of the ESKAPE pathogens, such as Klebsiella pneumoniae, Acinetobacter
baumannii, and Pseudomonas aeruginosa. Clinical isolates of P. aeruginosa have been found to be
resistant to most of the antibiotics normally used to treat this infection [140]. An unclassified
Levivirus P. aeruginosa phage PP7 has been identified which targets this bacterium via a pilin-specific
mechanism [141]. Further studies regarding the therapeutic parameters of RNA phages, such as PP7,
should be done to examine their efficiency to control these pathogens and to explore their potential
use as components of cocktails used in phage therapy.
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